Dr. Deming is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-265-1700Fax+1 608-890-7127
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 2010 - 2012- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 2007 - 2010
University of Wisconsin School of Medicine & Public HealthClass of 2007
Certifications & Licensure
WI State Medical License 2009 - 2025
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver Start of enrollment: 2020 Mar 16
- Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04) Start of enrollment: 2020 Jun 23
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group.Lakshmi Rajdev, Gentry G King, Christopher H Lieu, Stacey A Cohen, Shubham Pant
JCO Precision Oncology. 2025-03-01 - Cellpose as a reliable method for single-cell segmentation of autofluorescence microscopy images.Jeremiah M Riendeau, Amani A Gillette, Emmanuel Contreras Guzman, Mario Costa Cruz, Aleksander Kralovec
Scientific Reports. 2025-02-14 - Neoadjuvant SBRT plus Elective Nodal Irradiation with Concurrent Capecitabine for Patients with Resectable Pancreatic Cancer: Survival Analysis of a Prospective Phase ...Mustafa M Basree, Jacob S Witt, Nataliya V Uboha, Meghan Lubner, Rebecca Minter
Practical Radiation Oncology. 2025-02-07
Press Mentions
Monitoring ctDNA After Colorectal Cancer SurgeryFebruary 2nd, 2023
Cell-Free, Worry-Free: $10,000 Grant Expands Free Access to Personalized Cancer TestFebruary 28th, 2020- UW Carbone Experts Lead Sessions at World's Largest Cancer MeetingMay 31st, 2018
- Join now to see all
Grant Support
- Functional optical imaging for rapid, label-free predictions of treatment response and clonal evolution in patient-derived cancer organoidsMORGRIDGE INSTITUTE FOR RESEARCH, INC.2023–2028
- Functional optical imaging for rapid, label-free predictions of treatment response and clonal evolution in patient-derived cancer organoidsMORGRIDGE INSTITUTE FOR RESEARCH, INC.2023–2028
- Functional optical imaging for rapid, label-free predictions of treatment response and clonal evolution in patient-derived cancer organoidsMORGRIDGE INSTITUTE FOR RESEARCH, INC.2023–2028
- Functional optical imaging for rapid, label-free predictions of treatment response and clonal evolution in patient-derived cancer organoidsMORGRIDGE INSTITUTE FOR RESEARCH, INC.2023–2028
- Optical imaging to predict cell-level genetic heterogeneity and treatment sensitivity in colorectal cancerUNIVERSITY OF WISCONSIN-MADISON2018–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
